IP Verse

Diagnostic Test System For Specific, Sensitive And Reproducible Detection Of Circulating Nucleic Acids In Whole Blood - EP3358020

The patent EP3358020 was granted to Biodesix on May 19, 2021. The application was originally filed on Jan 5, 2018 under application number EP18150429A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3358020

BIODESIX
Application Number
EP18150429A
Filing Date
Jan 5, 2018
Status
Granted And Under Opposition
Apr 16, 2021
Publication Date
May 19, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

QIAGENFeb 21, 2022KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFWITHDRAWN

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS7824889
DESCRIPTIONUSRE43365E
OPPOSITIONEP3358020
OPPOSITIONWO2013045457
OPPOSITIONWO2014049022
OPPOSITIONWO2014146780
OPPOSITIONWO2014146781
OPPOSITIONWO2015140218
OPPOSITIONWO2016020710
SEARCHUS2016186239
SEARCHWO03089899
SEARCHWO2015063121
SEARCHWO2016020710

Non-Patent Literature (NPL) Citations (49) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- BEAVER et al., "Detection of cancer DNA in plasma of patients with early-stage breast cancer", Clin Cancer Res, (20140000), vol. 20, pages 2643 - 50
DESCRIPTION- JANNE et al., "AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer", N Engl J Med, (20150000), vol. 372, pages 1689 - 99
DESCRIPTION- OXNARD et al., "Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA", Clin Cancer Res, (20140000), vol. 20, pages 1698 - 705
DESCRIPTION- SAHNANE et al., "EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect", Clin Lung Cancer, (20160000), vol. 17, pages 56 - 61
DESCRIPTION- SALGIA, R., "Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach", Future Oncol, (20150000), vol. 11, pages 489 - 500
DESCRIPTION- SITHANANDAM et al., "B-raf and a B-raf pseudogene are located on 7q in man", Oncogene, (19920000), vol. 7, pages 795 - 9, XP008013456
DESCRIPTION- SITHANANDAM et al., "Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies", Oncogene, (19900000), vol. 5, pages 1775 - 80, XP009006652
DESCRIPTION- TAKESHITA et al., "Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer", Cancer Sci, (20150000), vol. 106, pages 1582 - 9
DESCRIPTION- WATANABE et al., "Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR", Clin Cancer Res, (20150000), vol. 21, pages 3552 - 60
DESCRIPTION- YU et al., "Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers", Clin Cancer Res, (20130000), vol. 19, pages 2240 - 7
DESCRIPTION- HINDSON et al., "High-throughput droplet digital PCR system for absolute quantitation of DNA copy number", Anal Chem, (20110000), vol. 83, doi:doi:10.1021/ac202028g, pages 8604 - 10, XP055047554
DESCRIPTION- VELCHETI et al., "Programmed death ligand-1 expression in non-small cell lung cancer", Lab Invest, (20140000), vol. 94, doi:doi:10.1038/labinvest.2013.130, pages 107 - 16, XP055431492
DESCRIPTION- DAVIES et al., "Mutations of the BRAF gene in human cancer", Nature, (20020000), vol. 417, doi:doi:10.1038/nature00766, pages 949 - 54, XP001188240
DESCRIPTION- LYNCH et al., "Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib", N Engl J Med, (20040000), vol. 350, doi:doi:10.1056/NEJMoa040938, pages 2129 - 39, XP002447439
DESCRIPTION- PAO et al., "EGF receptor gene mutations are common in lung cancers from ''never smokers'' and are associated with sensitivity of tumors to gefitinib and erlotinib", Proc Natl Acad Sci U S A, (20040000), vol. 101, doi:doi:10.1073/pnas.0405220101, pages 13306 - 11, XP002334314
DESCRIPTION- THOMPSON et al., "Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target", Proc Natl Acad Sci U S A, (20040000), vol. 101, doi:doi:10.1073/PNAS.0406351101, pages 17174 - 9, XP002520405
DESCRIPTION- PAEZ et al., "EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy", Science, (20040000), vol. 304, doi:doi:10.1126/science.1099314, pages 1497 - 500, XP002359959
DESCRIPTION- YU et al., "Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer", Clin Cancer Res, (20090000), vol. 15, doi:doi:10.1158/1078-0432.CCR-08-2739, pages 3023 - 8, XP055008859
DESCRIPTION- WEBER et al., "Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays", BMC Cancer, (20140000), vol. 14, doi:doi:10.1186/1471-2407-14-294, page 294, XP021184511
EXAMINATION- MARON J L ET AL, "Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood", JOURNAL OF CLINICAL INVESTIGATION, B M J GROUP, GB, vol. 117, no. 10, doi:10.1172/JCI29959, ISSN 0021-9738, (20071001), pages 3007 - 3019, (20070920), XP002579251
OPPOSITION- Anonymous, "A study of WT-ovation? PICO RNA amplification system performance", WT-OVATION? PICO RNA AMPLIFICATION SYSTEM (NuGEN), Technical Report # 2, (20060000), pages 1 - 4, XP055898226
OPPOSITION- Anonymous, "MinElute® Handbook", QIAGEN Handbook, (20080000), pages 1 - 48, XP055898210
OPPOSITION- Anonymous, "QIAamp® circulating nucleic acid Handbook", QIAGEN Handbook, (20131000), pages 1 - 56, XP002753499
OPPOSITION- Anonymous, "RNA Clean-u and Concentration Micro-Elute Kit Product Insert", NORGEN BIOTEK CORPORATION, (20150000), pages 1 - 9, XP055898221
OPPOSITION- Anonymous, "Spectacular is the new super- SuperScript IV VILO Master Mix", FisherEMEA-SuperScriptIV-VILO-Brochure, (20160000), pages 1 - 6, XP055898342
OPPOSITION- Anonymous, "Zymo Research product catalogue", The Epigenetics, (20150000), pages 1 - 220
OPPOSITION- "Basic techniques", Methods in molecular medicine - Hemostasis and thrombosis protocols, (19990000), pages 25 - 27, XP055898244
OPPOSITION- Greening D W; Glenister K M; Sparrow R L; Simpson R J, "International blood collection and storage: Clinical use of blood products", Journal of Proteomics, (20100000), vol. 73, no. 3, pages 386 - 395, XP026814947
OPPOSITION- HESTIA MELLERT et al., "Diagnostic test system for sensitive, specific and reproducible detection of EML4-ALK RNA fusion transcripts in the blood of patients with NSCLC", Proceedings of the 107th Annual Meeting of the American Association for Cancer Research, Philadelphia (PA, (20160416), pages 1 - 3, XP055898173
OPPOSITION- MELLERT et al., "Blood-based profiling of patients with NSCLC using CLIA certified cell-free DNA tests for EGFR, KRAS and BRAF point mutations and test use in clinical practice", Proceedings of the 107th Annual Meeting of the American Association for Cancer Research, Philadelphia (PA), (20160416), page 1, XP055898198
OPPOSITION- MELLERT et al., "Development of DDPCR blood-based diagnostic tests that simultaneously measure mRNA expression from immune and cancer cells", Clinical Immuno-Oncology Symposium, (20170301), pages 1 - 4, XP055898176
OPPOSITION- MELLERT et al., "Early feasibility and development of multiplexed, single-reaction assays for ALK, ROS1 and RET novel ddPCR RNA fusions", Proceedings of the American Association for Cancer Research Annual Meeting 2017, Washington, DC . Philadelphia (PA, (20170401), pages 1 - 3, XP055898195
OPPOSITION- MELLERT et al., "Rapid blood-based test for ALK, RET and ROS1 mRNA fusions and somatic variants in NSCLC", Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia (PA), (20151105), pages 1 - 4, XP055898183
OPPOSITION- DAS et al., "Stabilization of cellular RNA in blood during storage at room temperature: A comparison of cell -free RNA BCT® with K3EDTA tubes", Mol Diagn Ther, (20140000), vol. 18, doi:10.1007/s40291-014-0118-z, pages 647 - 653, XP055689504
OPPOSITION- CHOMCZYNSKI et al., "SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE-PHENOL-CHLOROFORM EXTRACTION", Anal Biochem, (19870000), vol. 162, no. 1, pages 156 - 159, XP000608462
OPPOSITION- MELLERT et al., "Development and clinical utility of a blood-based test service for the rapid identification of actionable mutations in non-small cell lung carcinoma", J Mol Diagn, (20170000), vol. 19, no. 3, doi:10.1016/j.jmoldx.2016.11.004, pages 404 - 416, XP055750469
OPPOSITION- HASTINGS et al., "Sensitive PCR-based quantitation of cell -free circulating microRNAs", Meth, (20120000), vol. 58, no. 2, doi:10.1016/j.ymeth.2012.07.026, pages 144 - 150, XP055479330
OPPOSITION- BYRON et al., "Translating RNA sequencing into clinical diagnostics: opportunities and challenges", Nat Rev Gen, (20160000), vol. 17, doi:10.1038/nrg.2016.10, pages 257 - 271, XP037065508
OPPOSITION- Catherine H Sterling; Isana Veksler-Lublinsky; Victor Ambros, "An efficient and sensitive method for preparing cDNA libraries form scarce biological samples", Nucleic Acids Research, (20140000), vol. 43, no. 1, pages 1 - 19, XP055587051
OPPOSITION- BUSCHMANN et al., "Toward reliable biomarker signatures in the age of liquid biopsies - how to standardize the small RNA-Seq workflow", Nucl Acids Res, (20160000), vol. 44, no. 13, pages 5995 - 6018, XP055386895
OPPOSITION- SAVELYEVA et al., "Variety of RNAs in peripheral blood cells, plasma, and plasma fractions", BioMed Res In t, (20170103), doi:10.1155/2017/7404912, pages 1 - 10, XP055872794
OPPOSITION- MARON et al., "Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood", J Clin Invest, (20070000), vol. 117, no. 10, doi:10.1172/JCI29959, pages 3007 - 3019, XP002579251
OPPOSITION- HUANG et al., "Characterization of human plasma-derived exosomal RNAs by deep sequencing", BMC Genomics, (20130000), vol. 14, no. 319, pages 1 - 14, XP021147887
OPPOSITION- STATHOPOULOU et al., "Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance", Journal of Clinical Oncology, (20020000), vol. 20, no. 16, pages 3404 - 3412, XP002407126
OPPOSITION- SPORNRAFT et al., "Optimization of extraction of circulating RNAs from plasma - enabling small RNA sequencing", PLOS ONE, (20140000), vol. 9, no. 9, doi:10.1371/journal.pone.0107259, page e107259, XP055492473
OPPOSITION- Head S R; Komori H K; LaMere S A; Whisenant T; Van Nieuwerburgh F; Salomon D R; Ordoukhanian P, "Library construction for next-generation sequencing: Overviews and challenges", Biotechniques, (20060000), vol. 56, no. 2, pages 61 - 64, 66 - 68-70, 72-74, 76-77, XP002740381
SEARCH- FUNAKI N ET AL, "PERIOPERATIVE QUANTITATIVE ANALYSIS OF CYTOKERATIN 20 MRNA IN PERIPHERAL VENOUS BLOOD OF PATIENTS WITH COLORECTAL ADENOCARCINOMA", ONCOLOGY REPORTS, NATIONAL HELLENIC RESEARCH FOUNDATION, (20000101), vol. 7, no. 2, ISSN 1021-335X, pages 271 - 276, XP000949330 [A] 1-10 * abstract *
SEARCH- SOETH E ET AL, "THE DETECTION OF DISSEMINATED TUMOR CELLS IN BONE MARROW FROM COLORECTAL-CANCER PATIENTS BY A CYTOKERATIN-20-SPECIFIC NESTED REVERSE-TRANSCRIPTASE-POLYMERASE-CHAIN REACTION IS RELATED TO THE STAGE OF DISEASE", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, US, (19960101), vol. 69, no. 4, doi:10.1002/(SICI)1097-0215(19960822)69:4<278::AID-IJC7>3.0.CO;2-U, ISSN 0020-7136, pages 278 - 282, XP000949379 [A] 1-10 * abstract *
SEARCH- BRITTA WEBER ET AL, "Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20140428), vol. 14, no. 1, doi:10.1186/1471-2407-14-294, ISSN 1471-2407, page 294, XP021184511 [X] 1,3,5-9 * abstract * * Methods *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents